Examples of 'antibody-dependent' in a sentence
Meaning of "antibody-dependent"
antibody-dependent (adjective): Relating to the immune response that involves antibodies
How to use "antibody-dependent" in a sentence
Basic
Advanced
antibody-dependent
Methods of enhancing antibody-dependent cellular cytotoxicity.
Antibody-dependent cellular cytotoxicity assay.
This phenomenon is referred to as antibody-dependent enhancement.
Detection of antibody-dependent cellular cytotoxicity in an in vitro model.
It induces apoptosis of these cells vía antibody-dependent cell cytotoxicity.
Three different antibody-dependent mechanisms are involved in this type of reaction.
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity.
Such antibody-dependent enhancement has been shown in cells and lab animals.
An aliquot of cells was used to perform antibody-dependent cellular cytotoxicity assays as follows.
In lytic antibodies this translates into an increased susceptibility to antibody-dependent cytolysis.
This process is called antibody-dependent cellular cytotoxicity.
In a further specific embodiment, the enhanced immune response is an increase in antibody-dependent cellular response.
Cytolysis may occur by induction of an antibody-dependent complement pathway, which is described above.
These monoclonal antibodies are also characterized by complement-mediated cytotoxic activity and antibody-dependent cellular cytotoxicity.
The mechanism of action is antibody-dependent lysis of leukemic cells following cell surface binding.
See also
The effector function that is reduced or altered may be antibody-dependent cytotoxicity.
Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use.
The antibody or fragment can be modified to enhance antibody-dependent cell killing.
Furthermore, in antibody-dependent enhancement of phagocytosis, the antibodies could only cause more severe PRRSV infections.
For use in the assay to determine binding, one may use an antibody-dependent cytotoxic system.
Antibody-dependent cell-mediated cytotoxicity assay.
The heteroantibody is capable of inducing complement-mediated cell lysis and antibody-dependent cell mediated cytolysis.
An antibody can be functional for antibody-dependent cytotoxicity and / or complement-mediated cytotoxicity.
The antibody mediates the lysis of lymphocytes via complement fixation and antibody-dependent cell mediated cytotoxicity.
Other mechanisms however, such as antibody-dependent cellular cytotoxicity and / or phagocytosis, may be possible.
Suitable antibodies for therapeutic treatment include for example, those which mediate antibody-dependent cell cytotoxicity.
This destruction takes place via an antibody-dependent cell elimination mechanism, in particular ADCC.
The complement cleavage product C4d is a marker for activation of the antibody-dependent classical pathway.
Antibody-dependent cell-mediated cytotoxicity was determined using the standard chromium 51 release assay.
The most widely accepted hypothesis is that of antibody-dependent enhancement ADE.
This is called antibody-dependent cellular cytotoxicity ( hereinafter abbreviated as ADCC ).
Another process involving Fc receptors is called antibody-dependent cell-mediated cytotoxicity ADCC.
It is believed that antibody-dependent cellular cytotoxicity ( ADCC ) plays an important role in immunotherapy.
They have properties that inhibit antibody-dependent cytotoxicity ;.
Antibody-dependent cell-mediated cytotoxicity ( ADCC ) requires antibodies to bind to target cell surfaces.
The second reason: antibody-dependent enhancement.
Adaptive immune responses could have contributed to disease severity, e . g ., by antibody-dependent enhancement.
This is thought to enhance its antibody-dependent cell-mediated cytotoxicity.
A panel of monoclonal antibodies against either CD47 or SIRPa, to enhance antibody-dependent killing.
Anti-zcytor19 monoclonal antibodies may enable antibody-dependent cellular cytotoxicity, complement dependent cytotoxicity, and phagocytosis.
Helps kill breast cancer cells that overexpress HER-2, possibly through antibody-dependent cytotoxicity.
This is therefore an antibody-dependent cellular cytotoxicity ( ADCC ).
For example, certain isotypes, such as IgG2a, have superior activity in antibody-dependent cellular cytotoxicity.
This mechanism is antibody-dependent cellular cytotoxicity ( ADCC ).
These include the existence of a phenomenon referred to as antibody-dependent enhancement ( ADE ).
One challenge is the antibody-dependent enhancement (ADE) of disease.
Example 2, In vivo evidence for a role of SIRPa signalling in antibody-dependent tumor cell killing.
FIGURE 7 illustrates antibody-dependent cell-mediated and complement-dependent cytotoxicity.
The first is based on inhibition of complement-mediated, antibody-dependent cytolysis by the antigen.
One of these mechanisms, the antibody-dependent cell-mediated cytotoxicity ( ADCC ), acts through activation of cytotoxic lymphocytes.
